XML 28 R6.htm IDEA: XBRL DOCUMENT v3.2.0.727
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
6 Months Ended
Aug. 01, 2015
Aug. 02, 2014
Cash flows from operating activities:    
Net loss $ (4,906) $ (10,316)
Adjustments to reconcile net loss to net cash flows from operating activities:    
Depreciation and amortization 22,390 20,049
Net gain on asset disposition (107) (2,707)
Provision (benefit) for store closures and asset impairment (2,840) 14,922
Stock-based compensation 928 1,364
Provision for uncollectible receivables 824 1,240
LIFO reserve increase 3,281 2,111
Deferred income tax benefit (3,511) (7,414)
Income tax charge upon exercise of stock options (214) (58)
(Increase) decrease in operating assets:    
Trade and non-trade receivables (8,675) $ 1,668
Insurance receivables (189)  
Inventories (6,034) $ 5,932
Other assets 1,951 901
Increase (decrease) in operating liabilities:    
Accounts payable and accrued expenses 3,947 (5,247)
Income taxes payable 8,443 (6,022)
Other noncurrent liabilities (2,464) 729
Net cash provided by operating activities 12,824 17,152
Cash flows from investing activities:    
Capital expenditures (10,301) (11,300)
Proceeds from asset dispositions 246 3,807
Asset acquisition , net (primarily intangibles) (6,533) $ (16,545)
Acquisition of Reeves-Sain Drug Store, Inc., net of cash (42,757)  
Net cash used in investing activities (59,345) $ (24,038)
Cash flows provided by (used in) financing activities:    
Proceeds from revolving line of credit 451,004 304,154
Payments on revolving line of credit (401,004) (291,175)
Payments of indebtedness and capital lease obligations (510) (992)
Proceeds from other long-term liabilities (410)  
Excess tax charges from stock-based compensation 214 58
Proceeds from exercise of stock options and employee stock purchase plan 2,199 622
Cash dividends paid (4,448) (4,418)
Net cash provided by financing activities 47,045 8,249
Increase in cash and cash equivalents 524 1,363
Cash and cash equivalents:    
Beginning of year 6,440 6,725
End of period 6,964 8,088
Supplemental disclosures of cash flow information:    
Interest paid 711 298
Income taxes paid 3,849 $ 8,021
Non-cash investing and financial activities:    
Acquisition related note payable, see Note 10 - Indebtedness 13,000  
Acquisition related contingent liability $ 1,000